HYFT
MindWalk Holdings Corp.
HYFT trails on the overall score without a compensating advantage in the available component scores.
LLY
Eli Lilly and Company
LLY has the edge over HYFT overall, supported by stronger fundamentals and lower modeled downside.
HYFT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Strong |
HYFT's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
HYFT PE Valuation
HYFT has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
HYFT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect HYFT's losses to grow, with revenue growing.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LLY has the edge over HYFT on the outlook, with more favorable earnings and profitability expectations.
HYFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2022 | -$0.75 | -$0.34 |
| Q2 2022 | -$0.60 | -$0.29 |
| Q1 2022 | -$0.65 | -$0.50 |
| Q4 2021 | -$0.57 | -$0.44 |
| Q3 2021 | -$0.41 | -$0.23 |
| Q2 2021 | -$0.31 | -$0.05 |
| Q1 2021 | -$0.15 | +$0.26 |
| Q4 2020 | -$0.13 | +$0.31 |
LLY has the stronger earnings trend. Trailing diluted EPS is down 135% for HYFT versus LLY up 51%.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY's earnings per share have climbed steadily: $30.81 over the past year, up 51% from the year before, and higher year over year for 11 quarters in a row.
HYFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.7M | +23% |
| Q2 2026 | $2.9M | -42% |
| Q1 2026 | $2.9M | -32% |
| Q4 2025 | $2.9M | -33% |
| Q3 2025 | $2.2M | -40% |
| Q2 2025 | $4.9M | +8.1% |
| Q1 2025 | $4.3M | -1.1% |
| Q4 2024 | $4.3M | -0.4% |
HYFT's revenue is recovering but still below its 2025 peak: $3M last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -160% | -28 points |
| Q2 2026 | -105% | -78 points |
| Q1 2026 | -95% | +304 points |
| Q4 2025 | -77% | -28 points |
| Q3 2025 | -132% | -42 points |
| Q2 2025 | -27% | +264 points |
| Q1 2025 | -399% | -343 points |
| Q4 2024 | -50% | -16 points |
HYFT's operating margin was −160% last quarter, down 28 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over HYFT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over HYFT on profitability, with a higher operating margin.
HYFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.9M | +$218.3K |
| Q2 2026 | -$1.8M | -$719.4K |
| Q1 2026 | -$2.1M | -$1.2M |
| Q4 2025 | -$2.1M | -$447.1K |
| Q3 2025 | -$3.2M | -$1.7M |
| Q2 2025 | -$1.1M | +$1.6M |
| Q1 2025 | -$924.5K | -$572.3K |
| Q4 2024 | -$1.6M | -$1.4M |
HYFT has burned cash in almost every quarter: −$9M over the past year, against −$7M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over HYFT on cash generation, producing positive trailing cash flow while its opponent burns cash.
HYFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2021 | -7.4x | Net Cash |
| Q4 2020 | -5.5x | Net Cash |
| Q3 2020 | -0.8x | Net Cash |
HYFT has more cash than debt.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
HYFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.9 | Neutral |
| Stochastic | 8.2 | Oversold |
HYFT's weekly RSI is 36 (neutral) and its Stochastic is 8 (oversold).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
HYFT PE vs Healthcare Sector
HYFT has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
HYFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.23 | 19% below |
| 20 week MA | $1.32 | 24% below |
| 50 week MA | $1.45 | 31% below |
| 100 week MA | $1.28 | 22% below |
| 200 week MA | $1.56 | 36% below |
HYFT is in a downtrend: it's below all five of its weekly moving averages, and 36% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over HYFT on trend strength, trading above more of its moving averages.
HYFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.20 | $16.4 | +645% |
| 2021 | $16.4 | $5.36 | -67% |
| 2022 | $5.36 | $5.72 | +6.7% |
| 2023 | $5.72 | $1.71 | -70% |
| 2024 | $1.71 | $0.41 | -76% |
| 2025 | $0.41 | $1.70 | +315% |
| 2026 YTD | $1.70 | $1.00 | -41% |
HYFT's yearly returns have swung widely, from +645% in 2020 to −76% in 2024. It's down 41% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over HYFT on returns for 2026, with the stronger performance.